| Protocol Number |
Title |
2003CG061
|
AGCT0132 A Phase III Study of Reduced Therapy in the Treatment of Children with Low and Intermediate Risk Extracranial Germ Cell Tumors |
2003NT024
|
GOG Protocol 0210: A Molecular Staging Study of Endometrial Carcinoma |
2005LS068
|
Phase I Hyperthermic Intraperitoneal Oxaliplatin for Peritoneal Malignancies |
2005NT019
|
A Non-Interventional Prospective Study of the Correlation of the Precision Therapeutics, Inc. Chemoresponse Assay with Progression-free Survival in Patients with Recurrent Epithelial Ovarian, Peritoneal or Fallopian Tube Cancer |
2006LS032
|
MT2005-21: Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors |
2006NT001
|
Biomarker with Biological Function in Ovarian Carcinoma/Diagnostic Markers for Ovarian Cancer: Detection of Novel Cell Adhesion Proteins in Patients' Specimens |
2007CG012
|
GOG Protocol 0212: A Randomized Phase III Trial of Maintenance Chemotherapy Comparing 12 Monthly Cycles of Single Agent Paclitaxel or CT-2103 (IND#70177) Versus No Treatment Until Documented Relapse in Women with Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer Who Achieve a Complete Clinical Response to Primary Platinum/Taxane Chemotherapy |
2007IS026
|
A Phase III, Multicenter, Randomized, Blinded, Placebo-Controlled Trial of Carboplatin and Gemcitabine Plus Bevacizumab in Patients with Platinum-Sensitive Recurrent Ovary, Primary Peritoneal, or Fallopian Tube Carcinoma (AVF4095g) |
2008CG146
|
GOG 0251: Phase II Trial of NCI-Supplied Agent: Bevacizumab for Recurrent Sex Cord-Stromal Tumors of the Ovary |
2008IS151
|
A Phase IIIb Open-Label, Multi-Centre Immunization Study to Evaluate the Safety of GlaxoSmithKline (GSK) Biologicals' HPV-16/18 L1 VLP AS04 Vaccine Administered Intramuscularly According to a 0,1,6-Month Schedule in Female American and Canadian Subjects Who Received the Active Control Hepatitis A Vaccine in the 580299/008 Study |
2008LS035
|
Phase I-II Trial of Genistein in Subjects Receiving Palliative External Beam Radiation Therapy for Osseous Metastases: A Study of Palliation of Symptoms and Quality of Life |
2008LS047
|
WCC #50 - Phase I Trial of Lenalidomide in Combination with Liposomal Doxorubicin for the Treatment of Recurrent Epithelial Ovarian, Fallopian Tube and Primary Peritoneal Cancer |
2008NTCG149
|
GOG 0215: A Phase II Randomized Study of the Effect of Zoledronic Acid Versus Observation on Bone Mineral Density of the Lumbar Spine in Women Who Elect to Undergo Risk-Reducing Surgery That Results in Removal of Both Ovaries |
2009CG019
|
GOG 240: A Randomized Phase III Trial of Cisplatin Plus Paclitaxel With and Without NCI-Supplied Bevacizumab (NSC #704865, IND #7921)Versus the Non-Platinum Doublet, Topotecan Plus Paclitaxel, With and Without NCI-Supplied Bevacizumab, in Stage IVB, Recurrent or Persistent Carcinoma of the Cervix |
2009CG030
|
GOG 249: A Phase III Trial of Pelvic Radiation Therapy Versus Vaginal Cuff Brachytherapy Followed by Paclitaxel/Carboplatin Chemotherapy in Patients with High Risk, Early Stage Endometrial Carcinoma |
2009NTCG043
|
GOG 214: Phase II Double Blind Randomized Trial Evaluating the Biological Effect of Levonorgestrel on the Ovarian Epithelium in Women at High Risk for Ovarian Cancer |
2009NTLS024
|
Diagnostic Magnetic Resonance Imaging and Spectroscopy of the Ovaries at 3 Tesla (T) |
Clinical Trials Help